A Network Pharmacology Study to Explore the Underlying Mechanism of Safflower (<i>Carthamus tinctorius L.</i>) in the Treatment of Coronary Heart Disease

<div>Go functional and KEGG pathway enrichment analysis. (a) GO function enrichment bubble chart of safflower in the treatment of CHD. (b) KEGG pathway analyses for the molecular signal pathway of safflower in the treatment of CHD. The node size represents the number of target genes enriched, and the node color from blue to red represents the P value from large to small. (c) FoxO signaling pathway. The targets associated with the core component-target-pathway network are represented by green rectangles.</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: A Network Pharmacology Study to Explore the Underlying Mechanism of Safflower (<i>Carthamus tinctorius L.</i>) in the Treatment of Coronary Heart Disease 

Figure 3 | A Network Pharmacology Study to Explore the Underlying Mechanism of Safflower (Carthamus tinctorius L.) in the Treatment of Coronary Heart Disease 